Dec. 15,
2004: Queen's-developed solar energy technology recieves
first U.S. patent
GO
>>
Oct. 25,
2004: Robotic invention for assessing motor skills
in stroke and spinal cord patients debuts at international
conference
GO
>>
Oct. 19,
2004: Queen’s-discovered ethanol extraction
process licensed to Xethanol Corp.
GO
>>
Aug. 25,
2004: Queen's University researchers issued 15 patents
in 2003-2004
GO
>>
June 21,
2004: New organization to focus on technology transfer
by Ontario’s academic research institutions
GO
>>
June 3,
2004: David Whiting appointed to PARTEQ Board of Directors
GO
>>
May 31,
2004: PARTEQ licensee Predictive
Patterns releases Genelinker™ Gold and Platinum
Version 4.5
GO
>>
May 5, 2004:
PARTEQ website sports new look, new approach to technology
transfer
GO
>>
April 20,
2004: New PARTEQ spinoff AtheroChem, Inc. to focus
on treatments for cholesterol-related heart disease
GO
>>
April 20,
2004: CIHR funds novel Queen's discoveries in back
pain, cholesterol control
GO
>>
March 24,
2004: Queen's cancer research technology licensed
to BD Biosciences
GO
>>
March
22, 2004: Queen's, McGill University spinoff
companies and NeuroSearch of Denmark join forces to
address chronic pain
GO
>>
Jan.
7, 2004: GB Therapeutics receives FDA approval to
begin clinical trials of Alzheimer's candidate
GO >>
Sept. 23, 2003: Performance
Plants completes $1.4 million financing round
GO >>
Mar. 17, 2003: CIHR
funds Queen's cholesterol research
GO >>
Feb. 24, 2003: International
IP experts launch PARTEQ educational series
GO >>
Feb. 12, 2003:
Venture funds fuel development of solar hot water
heater technology
GO >>
Feb. 3, 2003:
Performance Plants, Molecular Mining win KTC Awards
GO >>
Jan. 20, 2003:
Tri-university venture funds target emerging technologies
in energy and the environment
GO
>>
Jan. 9, 2003:
GB Therapeutics announces $4.5 million debenture round
and new Board of Directors
GO
>>
Jan. 9, 2003:
GB Therapeutics announces new CEO
GO
>>
